The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Open accessAbstract
Accumulating evidence suggests that neurodegeneration induced by pathogenic proteins depends on contributions from surrounding glia. Here we demonstrate that NF-kappaB signaling in microglia is critically involved in neuronal death induced by amyloid-beta (Abeta) peptides, which are widely presumed to cause Alzheimer disease. Constitutive inhibition of NF-kappaB signaling in microglia by expression of the nondegradable IkappaBalpha superrepressor blocked neurotoxicity, indicating a pivotal role for microglial NF-kappaB signaling in mediating Abeta toxicity. Stimulation of microglia with Abeta increased acetylation of RelA/p65 at lysine 310, which regulates the NF-kappaB pathway. Overexpression of SIRT1 deacetylase and the addition of the SIRT1 agonist resveratrol markedly reduced NF-kappaB signaling stimulated by Abeta and had strong neuroprotective effects. Our results support a glial loop hypothesis by demonstrating a critical role for microglial NF-kappaB signaling in Abeta-dependent neurodegeneration. They also implicate SIRT1 in this pathway and highlight the therapeutic potential of resveratrol and other sirtuin-activating compounds in Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a recent study it was found that over expression of SIRT1 deacetylase and SIRT1 activation by resveratrol significantly protects against microglia-dependent amyloid-β toxicity by inhibiting NF-kB signaling199.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,690
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M. E., Kamel, C., Chen, D., Gu, W. J., Bultsma, Y., McBurney, M. W., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,366
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Walker, 2002, Curr. Opin. Investig. Drugs, 3, 782
- Chen, 2005, Mol. Cell. Biol.
Cited by
Sorted by citations
Items 401–500 of 743
Impact of Gut Microbiota in Brain Ageing: Polyphenols as Beneficial Modulators
Sarubbo, F., Moranta, D., Tejada, S., Jiménez-García, M., & Esteban, S. (2023) · Antioxidants · doi:10.3390/antiox12040812 · Cited by 44
Teng, P., Li, Y., Cheng, W., Zhou, L., Shen, Y., & Wang, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1442 · Cited by 42
Jiang, N., Lv, J., Wang, H., Huang, H. M., Wang, Q., Zeng, G., Li, S., & Liu, X. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112710 · Cited by 42
Emerging Roles of Sirtuins in Ischemic Stroke
She, D. T., Jo, D., & Arumugam, T. V. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0544-4 · Cited by 41
Williams, A. C., Hill, L. J., & Ramsden, D. B. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/302875 · Cited by 42
Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Jalili, C., Kiani, A., Gholami, M., Bahrehmand, F., Fakhri, S., Kakehbaraei, S., & Kakebaraei, S. (2023) · IET Nanobiotechnology · doi:10.1049/nbt2.12127 · Cited by 43
Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders
Leite, J. A., Ghirotto, B., Targhetta, V. P., de Lima, J., & Câmara, N. O. S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15570 · Cited by 42
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Singh, M. K., Shin, Y., Ju, S., Han, S., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136901 · Cited by 43
Blocking SIRT1 inhibits cell proliferation and promotes aging through the PI3K/AKT pathway
Li, H., & Wang, R. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.09.037 · Cited by 39
Campagna, J. J., Spilman, P. R., Jagodzinska, B. M., Bai, D., Hatami, A., Zhu, C., Bilousova, T. V., Jun, M., Elias, C. J., Pham, J. D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35687-8 · Cited by 39
Sirtuin Modulators in Cellular and Animal Models of Human Diseases
Hong, J. Y., & Lin, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735044 · Cited by 40
Glial epigenetics in neuroinflammation and neurodegeneration
Staszewski, O., & Prinz, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1815-y · Cited by 39
Spinelli, M., Fusco, S., & Grassi, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123820 · Cited by 41
Circadian Rhythm Disruption and Alzheimer's Disease: The Dynamics of a Vicious Cycle
Sharma, A., Sethi, G., Tambuwala, M. M., Aljabali, A. A. A., Chellappan, D. K., Dua, K., & Goyal, R. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200429013041 · Cited by 50
Role of nuclear factor kappa B in central nervous system regeneration
Haenold, R., Engelmann, C., & Weih, F. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.131572 · Cited by 38
The Effects of SIRT1 on Alzheimer's Disease Models
Dönmez, G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/509529 · Cited by 38
Yeong, K. Y., Khaw, K. Y., Takahashi, Y., Itoh, Y., Murugaiyah, V., & Suzuki, T. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103403 · Cited by 37
SIRT1 activation by minocycline on regulation of microglial polarization homeostasis
Wu, L.-H., Huang, B., Lai, S., Lin, C., Lin, H., Yang, L., & Lu, D. (2020) · Aging · doi:10.18632/aging.103542 · Cited by 37
Gene expression patterns of the liver in response to alcohol: In vivo and in vitro models compared
Bardag‐Gorce, F., French, B. A., Dedes, J., Li, J., & French, S. W. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.12.006 · Cited by 37
An, Y., Li, Y., Hou, Y., Huang, S., & Pei, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3086010 · Cited by 37
Xu, L., Mi, Y., Meng, Q., Liu, Y., Wang, F., Zhang, G., Liu, Y., Chen, G., & Hou, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155344 · Cited by 36
Resveratrol as a Protective Molecule for Neuroinflammation: A Review of Mechanisms
Renaud, J., & Martinoli, M. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140617101332 · Cited by 37
Emerging Roles of Sirtuin 6 in Alzheimer’s Disease
Nasir, N. F. M., Zainuddin, A., & Shamsuddin, S. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-1005-y · Cited by 36
Sirt1’s Complex Roles in Neuroprotection
Tang, B. L. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9414-2 · Cited by 37
Rõlova, T., Puli, L., Magga, J. M., Dhungana, H., Kanninen, K. M., Wojciehowski, S., Salminen, A., Tanila, H., Koıstınaho, J., & Malm, T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.12.003 · Cited by 36
Resveratrol derivatives: a patent review (2009 – 2012)
Pezzuto, J. M., Kondratyuk, T. P., & Ogas, T. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.834888 · Cited by 36
Sirtuins in Neurodegenerative Diseases: A Biological-Chemical Perspective
Raghavan, A., & Shah, Z. A. (2011) · Neurodegenerative Diseases · doi:10.1159/000329724 · Cited by 36
Choi, B., Kim, S., Jang, B.-G., & Kim, M.-J. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.02.024 · Cited by 35
Sirt1 carboxyl-domain is an ATP-repressible domain that is transferrable to other proteins
Kang, H., Oka, S., Lee, D., Park, J. H., Aponte, A. M., Jung, Y., Bitterman, J. L., Zhai, P., He, Y., Kooshapur, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15560 · Cited by 36
Deng, L., Pushpitha, K., Joseph, C., Gupta, V. B., Rajput, R., Chitranshi, N., Dheer, Y., Amirkhani, A., Kamath, K. S., Pascovici, D., et al. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00024 · Cited by 34
Nuclear Sirtuins and the Aging of the Immune System
Gámez-García, A., & Vázquez, B. N. (2021) · Genes · doi:10.3390/genes12121856 · Cited by 36
Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders
Martínez-Iglesias, O. A., Naidoo, V., Carrera, I., Corzo, L., & Cacabelos, R. (2023) · Pharmaceuticals · doi:10.3390/ph16020216 · Cited by 39
Gebril, H. M., Aryasomayajula, A., de Lima, M. R. N., Uhrich, K. E., & Moghe, P. V. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00393-7 · Cited by 37
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2018) · BioMed Research International · doi:10.1155/2018/1483791 · Cited by 36
Sabaani, N. A. A. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0151 · Cited by 34
Caruso, G. I., Spampinato, S. F., Costantino, G., Merlo, S., & Sortino, M. A. (2021) · Biomedicines · doi:10.3390/biomedicines9050466 · Cited by 35
Lattanzio, F., Carboni, L., Carretta, D., Rimondini, R., Candeletti, S., & Romualdi, P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.017 · Cited by 34
Li, P., Jin, Y., Qi, F., Wu, F., Luo, S., Cheng, Y., Montgomery, R. R., & Qian, F. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00113 · Cited by 34
Mehramiz, M., Porter, T., O’Brien, E. K., Rainey‐Smith, S. R., & Laws, S. M. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220088 · Cited by 37
Yao, K., Mou, Q., Lou, X., Ye, M., Zhao, B., Hu, Y., Luo, J., Zhang, H., Li, X., & Zhao, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02886-8 · Cited by 33
Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
Dreyer, J. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9334-x · Cited by 35
Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy
Morató, L., Ruíz, M., Boada, J., Calingasan, N. Y., Galino, J., Guilera, C., Jové, M., Naudí, A., Ferrer, I., Pamplona, R., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.20 · Cited by 33
Lee, J. C., Shin, J.-H., Park, B.-W., Kim, G. S., Kim, J. C., Kang, K.-S., & Cha, C. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.11.019 · Cited by 32
Small-Molecule Chromatin-Modifying Agents: Therapeutic Applications
Mai, A. (2010) · Epigenomics · doi:10.2217/epi.10.7 · Cited by 33
Go, J., Ha, T. K. Q., Seo, J. Y., Park, T., Ryu, Y., Park, H., Noh, J., Kim, Y., Hwang, J. H., Choi, D., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.02.002 · Cited by 32
Fernández-Ruiz, J. C., Ramos-Remus, C., Sánchez‐Corona, J., Castillo-Ortiz, J. D., Castaneda-Sanchez, J. J., Bastián, Y., Romo-García, M. F., Ochoa-González, F. D. L., Monsiváis-Urenda, A. E., González‐Amaro, R., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.07.028 · Cited by 32
Marı́n, C., Langdon, C., Alobid, I., Fuentes, M., Bonastre, M., & Mullol, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1472-y · Cited by 31
Ro, J.-H., Liu, C.-C., & Lin, M. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02497-x · Cited by 32
Role of Sirtuins in Physiology and Diseases of the Central Nervous System
Chojdak-Łukasiewicz, J., Bizoń, A., Waliszewska‐Prosół, M., Piwowar, A., Budrewicz, S. P., & Pokryszko‐Dragan, A. (2022) · Biomedicines · doi:10.3390/biomedicines10102434 · Cited by 33
TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women
Lü, Y., Liu, P., Recker, R. R., Deng, H., & Dvornyk, V. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181d5d523 · Cited by 32
Martorana, F., Foti, M., Virtuoso, A., Gaglio, D., Aprea, F., Latronico, T., Rossano, R., Riccio, P., Papa, M., Alberghina, L., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8056904 · Cited by 31
SIRT1 regulates O-GlcNAcylation of tau through OGT
Lu, S., Yin, X., Wang, J., Gu, Q., Huang, Q., Jin, N., Chu, D., Xu, Z., Liu, F., & Qian, W. (2020) · Aging · doi:10.18632/aging.103062 · Cited by 31
Pregnancy as a model for aging
Giller, A., Andrawus, M., Gutman, D., & Atzmon, G. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101093 · Cited by 33
Caspase‐mediated changes in Sir2α during apoptosis
Ohsawa, S., & Miura, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.051 · Cited by 31
GUO, P., WANG, D., WANG, X., FENG, H., TANG, Y., SUN, R., ZHENG, Y., DONG, L., ZHAO, J., ZHANG, X., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4957 · Cited by 30
Wang, C., Zou, W., Liang, X., Jiang, Z., Li, X., Wei, H., Tang, Y.-Y., Zhang, P., & Tang, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7004 · Cited by 29
Kim, H. J., Joe, Y., Chen, Y., Park, G. H., Kim, U., & Chung, H. (2018) · Aging Cell · doi:10.1111/acel.12864 · Cited by 32
Potential implications of polyphenolic compounds in neurodegenerative diseases
Shi, R., Gao, D., Stoika, R. S., Liu, K., Attila Gabor, S. I. K., & Jin, M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2155106 · Cited by 33
CYB5R3: a key player in aerobic metabolism and aging?
de Cabo, R., Siendones, E., Minor, R. K., & Navas, P. (2009) · Aging · doi:10.18632/aging.100112 · Cited by 30
HSP60 is involved in the neuroprotective effects of naloxone
Cheng, W., Li, Y., Hou, X., Zhang, N., Ma, J., Ding, F., LI, F., MIAO, Z., ZHANG, Y., Qi, Q., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2411 · Cited by 30
Interaction between resveratrol and SIRT1: role in neurodegenerative diseases
Zhu, L., Yang, M., Fan, L., Yan, Q., Zhang, L., Mu, P., & Lu, F. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03319-w · Cited by 31
The neuroprotective effect of resveratrol on retinal ganglion cells after optic nerve transection.
Kim, S., Park, J. H., Kim, K. G., & Park, K. H. (2013) · Europe PMC (PubMed Central) · Cited by 28
Groundnut (Peanut) (Arachis hypogaea)
Syed, F., Arif, S., Ahmed, I., & Khalid, N. (2020) · Springer eBooks · doi:10.1007/978-981-15-4194-0_4 · Cited by 34
Wątroba, M., & Szukiewicz, D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.962769 · Cited by 29
Xu, Q., Su, Z., Hu, Z. J., Yang, W., Xian, Y., & Lin, Z. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154441 · Cited by 30
Díaz-Ruiz, C., Rodriguez-Perez, A. I., Beiroa, D., Rodríguez‐Pallares, J., & Labandeira-García, J. L. (2015) · Oncotarget · doi:10.18632/oncotarget.5596 · Cited by 29
CD38 is a key enzyme for the survival of mouse microglial BV2 cells
Ma, Y., Jiang, J., Wang, L., Nie, H., Xia, W., Liu, J., & Ying, W. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.084 · Cited by 29
Nazari, S., Pourmand, S. M., Motevaseli, E., & Hassanzadeh, G. (2023) · IUBMB Life · doi:10.1002/iub.2759 · Cited by 29
NF-κΒ Signaling in Neurite Growth and Neuronal Survival
Teng, F. Y. H., & Tang, B. L. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.4.299 · Cited by 28
Braidy, N., Grant, R., & Sachdev, P. S. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000394 · Cited by 27
Chowdhury, S., Sripathy, S. P., Webster, A. A., Park, A., Lao, U., Hsu, J. H., Loe, T. K., Bedalov, A., & Simon, J. A. (2020) · Molecules · doi:10.3390/molecules25030455 · Cited by 28
Lei, J., Shen, Y., Xv, G., Di, Z., Li, Y., & Li, G. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1765373 · Cited by 28
Lifestyle modifications with anti-neuroinflammatory benefits in the aging population
Muscat, S. M., & Barrientos, R. M. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111144 · Cited by 30
Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1832-6 · Cited by 30
Yeong, K. Y., & Choon, T. S. (2015) · Archiv der Pharmazie · doi:10.1002/ardp.201500337 · Cited by 27
Kılıç, Ü., Elibol, B., Uysal, Ö., Kılıç, E., Yuluğ, B., Şakul, A., & Yıldız, G. B. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.018 · Cited by 28
Sung, J. Y., Kim, S. G., Kim, J.-R., & Choi, H. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239976 · Cited by 26
Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs
Medrano-Jiménez, E., Meza‐Sosa, K. F., Aragon, J. A. U., Secundino, I., Pedraza-Alva, G., & Pérez-Martínez, L. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr1021-531r · Cited by 28
Targeting Mitochondrial Sirtuins in Age-Related Neurodegenerative Diseases and Fibrosis
Xiao, H., Xie, Y., Xi, K., Xie, J., Liu, M., Zhang, Y., Cheng, Z., Wang, W., Guo, B., & Wu, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0203 · Cited by 29
Tian, Q., Fan, X., Ma, J., Han, Y., Li, D., Jiang, S., Zhang, F., Guang, H., Shan, X., Chen, R., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115261 · Cited by 28
Activation of Microglia by Borna Disease Virus Infection: In Vitro Study
Ovanesov, M. V., Sauder, C. J., Rubin, S. A., Richt, J. A., Nath, A., Carbone, K. M., & Pletnikov, M. V. (2006) · Journal of Virology · doi:10.1128/jvi.01648-06 · Cited by 27
Moon, M.-Y., Kim, H.-J., Li, Y., Kim, J.-G., Jeon, Y.-J., Won, H.-Y., Kim, J.-S., Kwon, H.-Y., Choi, I.-G., Ro, E., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.05.023 · Cited by 27
Self-citationLiao, H., Huang, J., Liu, J., Zhu, H., Chen, Y., Li, X., Wen, J., & Yang, Q. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08167-6 · Cited by 26
Modulators of microglia: a patent review
Papa, S., Caron, I., Rossi, F., & Veglianese, P. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1135901 · Cited by 26
Sirtuins, a key regulator of ageing and age-related neurodegenerative diseases
Bhatt, V., & Tiwari, A. K. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2057849 · Cited by 28
Sanjay, S., Park, M., & Lee, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137300 · Cited by 28
Balaha, M. F. H., Alamer, A., Eisa, A. A., & Aljohani, H. M. (2023) · Antibiotics · doi:10.3390/antibiotics12050826 · Cited by 26
Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer’s agents
Ordoñez, W. O. C., Cajas‐Salazar, N., & Velasco-Reyes, M. A. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382232 · Cited by 26
Huang, P.-S., Son, J., Abbott, L. C., & Winzer‐Serhan, U. H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.007 · Cited by 27
Zinc homeostasis and signaling in glia
Sekler, I., & Silverman, W. F. (2012) · Glia · doi:10.1002/glia.22286 · Cited by 26
Mormone, E., Iorio, E. L., Abate, L., & Rodolfo, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1073689 · Cited by 31
Yang, S. B., Lee, S. M., Park, J., Lee, T. H., Baek, N., Park, H., Lee, H., & Kim, J. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00939 · Cited by 25
Inoue, H., Kishimoto, A., Ushikoshi‐Nakayama, R., Hasaka, A., Takahashi, A., Ryo, K., Muramatsu, T., Ide, F., Mishima, K., & Saito, I. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-31 · Cited by 27
Mendonca, P., Taka, E., Bauer, D., Reams, R., & Soliman, K. F. A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.09.004 · Cited by 25
Okuda, M., Fujita, Y., & Sugimoto, H. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00332 · Cited by 27
Maggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Sirtuins as Modifiers of Huntington's Disease (HD) Pathology
Neo, S. H., & Tang, B. L. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.013 · Cited by 25
Gastrodin alleviates Tourette syndrome via Nrf‐2/HO‐1/HMGB1/NF‐кB pathway
Long, H., Ruan, J., Mengjiao, Z., Wang, C., & Huang, Y. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22389 · Cited by 24
Mitochondrial sirtuins – a new therapeutic target for repair and protection in multiple sclerosis
Rice, C. M., Sun, M., Kemp, K. C., Gray, E., Wilkins, A., & Scolding, N. J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08150.x · Cited by 25
CD40 promotion of amyloid beta production occurs via the NF‐κB pathway
Ait‐Ghezala, G., Volmar, C., Frieling, J. S., Paris, D., Tweed, M., Bakshi, P., & MULLAN, M. J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05424.x · Cited by 24
Metadata
- Authors
- Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Gan, Li
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 280
- Issue
- 48
- Pages
- 40364-40374
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2074916731
- Cited by
- 740
- References
- 54
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 35 · 2023: 36 · 2022: 22 · 2021: 39 · 2020: 49 · 2019: 30 · 2018: 46 · 2017: 40 · 2016: 26 · 2015: 35 · 2014: 35 · 2013: 48 · 2012: 43
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University of California, San Francisco
- National Institute of Neurological Disorders and Stroke (NS43945, R01NS043945)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- SIRT1, microglia, amyloid-beta, NF-κB signaling, Alzheimer's disease, neurodegeneration, resveratrol, neuroprotection
- MeSH terms
- Resveratrol, Alzheimer Disease, Animals, Bromodeoxyuridine, Cells, Cultured, Genetic Vectors, Humans, Immunohistochemistry, Lysine, Microscopy, Fluorescence, Models, Biological, Models, Genetic, Neurons, Stilbenes, Signal Transduction, Lentivirus, Amyloid beta-Peptides, NF-kappa B, Rats, Sprague-Dawley, Microglia, Genes, Reporter, Reverse Transcriptase Polymerase Chain Reaction, Sirtuins, Green Fluorescent Proteins, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review